E. Starostina

Association of blindness to intensification of glycemic control in insulin-dependent diabetes mellitus.

E. Chantelau, G. Galstyan, M. Antsiferov, 1994, Journal of diabetes and its complications.

CAUSES OF DEATH IN PATIENTS WITH DIABETES MELLITUS, THYROID DISORDERS AND OBESITY: A CLINICIAN’S PERSPECTIVE

E. Starostina, 2019, Russian Journal of Forensic Medicine.

Neuroleptic-Associated Hyperprolactinemia: Clinical Manifestations and Effects on Sexual Function

I. Dedov, L. Dzeranova, E. Starostina, 2018, Neuroscience and Behavioral Physiology.

[Hyperprolactinemia associated with neuroleptic treatment: clinical characteristics and an impact on sexual function].

I. Dedov, L. Dzeranova, E. Starostina, 2016, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[Antihypertensive treatment compliance and obstacles to its improvement. Results of Russian program ARGUS-2].

O. Kisliak, E. Baranova, V. V. Maksimenko, 2008, Terapevticheskii arkhiv.

Effectiveness and cost-benefit analysis of intensive treatment and teaching programmes for Type 1 (insulin-dependent) diabetes mellitus in Moscow—blood glucose versus urine glucose self-monitoring

I. Mühlhauser, U. Bott, M. Berger, 1994, Diabetologia.

Continuous monitoring blood glucose level in clinical practice and new methods for its analysis

A. Dreval, O. Dreval, E. Starostina, 2013 .